- Home
- BLDE vs TERN Comparison
BLDE vs TERN Comparison
Compare BLDE & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- TERN
- Stock Information
- Founded
- BLDE 2014
- TERN 2017
- Country
- BLDE United States
- TERN United States
- Employees
- BLDE N/A
- TERN N/A
- Industry
- BLDE Aerospace
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- TERN Health Care
- Exchange
- BLDE Nasdaq
- TERN Nasdaq
- Market Cap
- BLDE 272.5M
- TERN 298.1M
- IPO Year
- BLDE N/A
- TERN 2021
- Fundamental
- Price
- BLDE $2.83
- TERN $2.49
- Analyst Decision
- BLDE Strong Buy
- TERN Buy
- Analyst Count
- BLDE 2
- TERN 5
- Target Price
- BLDE $6.25
- TERN $18.38
- AVG Volume (30 Days)
- BLDE 676.7K
- TERN 1.0M
- Earning Date
- BLDE 03-13-2025
- TERN 05-12-2025
- Dividend Yield
- BLDE N/A
- TERN N/A
- EPS Growth
- BLDE N/A
- TERN N/A
- EPS
- BLDE N/A
- TERN N/A
- Revenue
- BLDE $248,693,000.00
- TERN N/A
- Revenue This Year
- BLDE $5.29
- TERN N/A
- Revenue Next Year
- BLDE $8.99
- TERN N/A
- P/E Ratio
- BLDE N/A
- TERN N/A
- Revenue Growth
- BLDE 10.44
- TERN N/A
- 52 Week Low
- BLDE $2.60
- TERN $2.46
- 52 Week High
- BLDE $5.17
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- BLDE 37.19
- TERN 25.94
- Support Level
- BLDE $2.65
- TERN $3.07
- Resistance Level
- BLDE $3.21
- TERN $3.72
- Average True Range (ATR)
- BLDE 0.15
- TERN 0.22
- MACD
- BLDE 0.00
- TERN -0.04
- Stochastic Oscillator
- BLDE 26.09
- TERN 2.38
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.